Back to search
FDAFDA · Food and drugs·Recall number D-0313-2025

Sofosbuvir and Velpatasvir, 400 mg/100 mg tablets, 28 tablets: 2x14 blister cards, Rx Only, Manufactured for: Asegua Therapeutics LLC an affiliate of Gilead Sciences, Inc., Foster City, CA 94404, Made in Ireland, NDC# 72626-2701-1

Published April 16, 2025 · Recall initiated: March 7, 2025

Summary

FDA records drug Class II recall D-0313-2025, published April 16, 2025 and initiated March 7, 2025. Recalling firm: ASEGUA THERAPEUTICS LLC; Status: Ongoing; Reported quantity: 18,541 cartons.; Lot: Lot# 24ASV002UA, Exp Date: 6/30/2028. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Defective Container: blister packs not properly sealed resulting in tablets being loose in the carton.

What to do

Voluntary: Firm initiated · Letter

Get an email if SOFOSBUVIR AND VELPATASVIR has another recall

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Brand
SOFOSBUVIR AND VELPATASVIR
Manufacturer
ASEGUA THERAPEUTICS LLC
Distributor
US Nationwide
Lot
Lot# 24ASV002UA, Exp Date: 6/30/2028
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Sofosbuvir and Velpatasvir, 400 mg/100 mg tablets, 28 tablets: 2x14 blister cards, Rx Only, Manufactured for: Asegua Therapeutics LLC an affiliate of Gilead Sciences, Inc., Foster City, CA 94404, Made in Ireland, NDC# 72626-2701-1 recalled?

Yes. FDA published recall D-0313-2025 on April 16, 2025. Reported hazard: Defective Container: blister packs not properly sealed resulting in tablets being loose in the carton.

What should I do if I have this product?

Voluntary: Firm initiated · Letter

How do I know if my unit is part of the recall?

Compare your product details with the notice. Brand: SOFOSBUVIR AND VELPATASVIR.